Sector dividends Neurizon Therapeutics Limited

Stocks

Delayed Australian S.E. Other stock markets 09:24:46 18/06/2026 am IST			5-day change	1st Jan Change
0.0650 ^AUD	-4.41%		+8.33%	-23.53%

12/06	Neurizon Therapeutics Surpasses 50% Dosing Milestone in Trial of ALS Treatment	MT
27/05	Neurizon Therapeutics Limited Expands Regimen I of the Healey Als Platform Trial to 240 Participants	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Dividend Yield (Y)	Dividend Yield (Y+1)	P/E (Y)	Price to Book (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Capi.($)
NEURIZON THERAPEUTICS LIMITED	-	-	-	-	-	-	-	3.59Cr
ELI LILLY AND COMPANY	0.61%	0.67%	32.85x	19.6x	11.94x	24.59x	25.07x	99TCr
JOHNSON & JOHNSON	2.27%	2.37%	25.13x	6.33x	5.79x	15.76x	17.42x	56TCr
ABBVIE INC.	3.09%	3.25%	27.6x	-809.84x	6.65x	13.6x	13.96x	39TCr
ROCHE HOLDING AG	3.09%	3.17%	17.38x	6.41x	4.29x	10.55x	11.91x	33TCr
ASTRAZENECA PLC	1.87%	1.98%	22.34x	5.2x	4.67x	13.24x	13.92x	28TCr
NOVARTIS AG	2.97%	3.05%	20.88x	6.26x	5.41x	13.12x	14.33x	28TCr
NOVO NORDISK A/S	4.05%	3.88%	12.39x	5.42x	4.65x	9.51x	11.16x	20TCr
AMGEN INC.	2.9%	3.06%	22.62x	16.86x	6.06x	10.58x	13.87x	18TCr
GILEAD SCIENCES, INC.	2.55%	2.61%	-45.59x	8.64x	5.5x	30.32x	61.19x	16TCr
PFIZER INC.	6.73%	6.7%	12.18x	1.69x	3.19x	7.76x	9.03x	15TCr
VERTEX PHARMACEUTICALS INCORPORATED	-.--%	-.--%	25.91x	5.2x	7.84x	17.68x	18.41x	12TCr
BRISTOL-MYERS SQUIBB COMPANY	4.5%	4.62%	10.96x	4.85x	3.02x	8.06x	8.76x	11TCr
SANOFI	5.62%	5.96%	11.25x	1.21x	2.16x	6.98x	7.92x	10TCr
GSK PLC	3.59%	3.76%	12.52x	4.63x	2.73x	8.02x	9.05x	11TCr
CHUGAI PHARMACEUTICAL CO., LTD.	1.82%	2.08%	24.25x	5.51x	8.26x	15.62x	16.34x	7.86TCr
TAKEDA PHARMACEUTICAL COMPANY LIMITED	3.98%	4.07%	44.67x	1.11x	2.62x	9.67x	27.41x	4.87TCr
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	0.58%	0.64%	33.66x	4.55x	7.44x	24.81x	25.64x	4.6TCr
BAYER AG	0.61%	2.05%	15.3x	1.25x	1.47x	6.98x	11.62x	4.3TCr
Average	2.82%	3%	18.13x	-39.17x	5.20x	13.71x	17.61x	21.97TCr
Weighted average by Cap.	2.41%	2.51%	21.48x	-67.06x	6.77x	16.00x	18.40x